Next Generation Sequencers Market Revenue Predicted to Go Up by 2024
Global Next Generation Sequencers Market: Overview
Next
generation sequencing (NGS) has opened a whole new avenue for
researchers to study biological systems at a level never before
possible, reaching new heights with its unprecedented speed, throughput,
and scalability. Beyond the limited capacity of traditional DNA
sequencing technologies, next generation sequencers provide answers to
critical genomic research questions and is now becoming an everyday
research tool. The next generation sequencing technology helps in rapid
sequencing and produces thousands to millions of sequences in a single
run. Owing to this escalated usefulness, the global next generation
sequencers market is projected for a healthy CAGR during the forecast
period of 2016 to 2024.
This
report on next generation sequencers is a thorough study of the global
market, which has been developed to help current and future players to
make more informed choices for their business. The report not only
analyzes all the factors that are expected to influence the market and
presents a figurative future estimation, it also profiles some of the
key companies currently operation in global next generation sequencers
market for their market share, product portfolio, and other strategic
developments.
Request for Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=574
Based
on technology, the market can be segmented into single-molecule
real-time sequencing (SMRT), pyrosequencing, ion semiconductor
sequencing, sequencing by ligation, sequencing by synthesis, and chain
termination. Since all these technologies are proprietary and protected
through intellectual property rights, new players must develop
independent technology to make a market over the market. By application,
the market can be segmented into oncology, reproductive health, immune
system monitoring, agrigenomics and forensics, consumer genomics, and
clinical investigations including infectious disease, inherited
diseases, idiopathic diseases, and non-communicable diseases.
Global Next Generation Sequencers Market: Trends and Opportunities
Growing
automation in the pre-sequencing protocols is expected to drive the
global next generation sequencers market during the forecast period.
Utilization of new platforms for the development of personalized
medicine by genetic level medical analysis is another prominent factor
expected to escalate the demand for NGS over the forecast period. The
report also expects the increased number of research and development
projects in the field of metabolomics, transcriptomics, and proteomics
to reflect on global next generation sequencers market. Some of the
other factors driving the market are increasing adoption among
researchers, academicians and customers, growing healthcare expenditure
for the development of effective diagnostic and therapeutic procedure
for cancer, low cost DNA sequencing, and microarray technology by NGS.
Conversely,
the lack of computational efficiency for data management, non-value
based NGS reimbursement policy and regulation status, and challenges
associated with NGS implementations are the factors that may hinder the
growth rate during the forecast period.
Global Next Generation Sequencers Market: Region-wise Outlook
North
America currently contributes to the maximum demand in next generation
sequencers market and the demand is expected to sustain over the
duration of forecast period, primarily from the developed economies of
the U.S. and Canada, who have technologically advanced healthcare
framework and high adoption rate of new technologies. Several prominent
companies in this field are based out of the U.S., which also reflects
on heavy investments on research and development in the country. Europe
market for next generation sequencers is also formidable, as the
majority of respondents for academic and clinical use are located in the
U.K. and Germany. For instance, Illumina Inc. inaugurated its European
headquarters in Cambridge in 2015, taking initiative to gain share of
revenue generated through 10,000 genome project carried out in the
country. Asia Pacific, though a smaller regional market as of now, is
projected for most robust growth rate among all the regions, owing to
improving healthcare infrastructure in the emerging economies of India
and China.
Companies Mentioned in the Research Report
Some
of the key companies currently operational in global next generation
sequencers market are Pacific Biosciences, Illumina Inc., Beijing
Genomics Institute, F Hoffman-La Roche, Oxford Nanopore Technologies
Inc., GATC Biotech AG., Thermo Fisher Scientific, Agilent Technologies
Inc., Biomatters Ltd., Helicos BioSciences, DNAStar Inc., Macrogen Inc.,
CLC Bio (Qiagen), and Knome Inc.
Comments
Post a Comment